--- title: "Bayer has Tony Romo calling plays in Nubeqa drive" type: "News" locale: "en" url: "https://longbridge.com/en/news/274176309.md" description: "Bayer has launched a new marketing campaign for its prostate cancer drug Nubeqa, featuring former NFL quarterback Tony Romo. The \"Highlights REAL\" campaign includes videos where Romo interacts with patients and caregivers, aiming to raise awareness about prostate cancer. The campaign coincides with heightened interest in football, although Bayer will not air a Super Bowl ad. Nubeqa, which received FDA approval in 2019, has seen significant sales growth, achieving blockbuster status in 2024 with a 56% increase in sales over the first nine months of the previous year." datetime: "2026-01-29T15:48:22.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/274176309.md) - [en](https://longbridge.com/en/news/274176309.md) - [zh-HK](https://longbridge.com/zh-HK/news/274176309.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/274176309.md) | [繁體中文](https://longbridge.com/zh-HK/news/274176309.md) # Bayer has Tony Romo calling plays in Nubeqa drive Bayer has unveiled the next play in its Nubeqa marketing strategy, tapping NFL quarterback-turned-CBS commentator Tony Romo for a campaign in support of its fast-growing prostate cancer drug. The “Highlights REAL” campaign, which Bayer kicked off Thursday, stars Romo, who played for the Dallas Cowboys before stepping into the commentary booth, in a series of videos about life with prostate cancer. Across a trio of clips, Romo talks with a patient taking Nubeqa, a caregiver of a person with advanced prostate cancer and an oncologist. Romo’s father, Ramiro, who has faced prostate cancer but isn’t a Nubeqa patient, joins his son in the main video on the branded campaign website. Sitting side by side, Tony and Ramiro provide play-by-play commentary on advanced prostate cancer patients and their caregivers going about their lives, including by making model cars, playing softball, brewing coffee, fishing and cooking. Bayer said in the campaign launch announcement that the commentary is intended to fuel “a deeper appreciation for everyday moments, both big and small,” and to spark conversations about prostate cancer. The company’s football-centric prostate cancer push debuted the same day as another Big Pharma’s: Novartis on Thursday unveiled an ad set to air during Super Bowl LX on Feb. 8 that also features NFL stars talking about the disease, though Novartis took an unbranded approach with its campaign, which focuses primarily on encouraging men to undergo regular prostate-specific antigen blood tests for early detection. Bayer didn’t list a Super Bowl ad among its campaign’s outreach channels, and, with the big game airing on NBC next month, CBS-based Romo won’t be calling it this year. But, with Bayer’s campaign coinciding with a period when football is very much in the national spotlight, the drugmaker could certainly benefit from the annual surge in interest in the sport. Nubeqa, a key product for the drugmaker, won FDA approval in 2019, but it took a few years for the launch to kick into high gear. Having recorded its first year of blockbuster Nubeqa sales in 2024, Bayer maintained the momentum with 56% growth over the first nine months of last year. ### Related Stocks - [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md) - [State Street®HlthCrSelSectSPDR®ETF (XLV.US)](https://longbridge.com/en/quote/XLV.US.md) - [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md) - [iShares US Medical Devices ETF (IHI.US)](https://longbridge.com/en/quote/IHI.US.md) - [Bayer AG (BAYN.DE)](https://longbridge.com/en/quote/BAYN.DE.md) - [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md) - [Vanguard Health Care ETF (VHT.US)](https://longbridge.com/en/quote/VHT.US.md) - [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md) - [ARK Genomic Revolution ETF (ARKG.US)](https://longbridge.com/en/quote/ARKG.US.md) - [iShares Global Healthcare ETF (IXJ.US)](https://longbridge.com/en/quote/IXJ.US.md) - [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md) - [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md) - [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md) - [iShares US Pharmaceuticals ETF (IHE.US)](https://longbridge.com/en/quote/IHE.US.md) - [Bayer Aktiengesellschaft (BAYZF.US)](https://longbridge.com/en/quote/BAYZF.US.md) - [SPDR® S&P Health Care Equipment ETF (XHE.US)](https://longbridge.com/en/quote/XHE.US.md) ## Related News & Research - [UK Regulator OKs Bayer's Treatment for Advanced Non-small Cell Lung Cancer](https://longbridge.com/en/news/281501722.md) - [Bayer rejigs marketing claims after advertising body challenge](https://longbridge.com/en/news/281525890.md) - [Bayer under pressure following activist investor exit](https://longbridge.com/en/news/280312617.md) - [Bayer Announces Approval Of New Indication For Kerendia In The EU](https://longbridge.com/en/news/280969658.md) - [Bayer signs Ludacris to One A Day multivitamin campaign](https://longbridge.com/en/news/280813113.md)